Takayuki Mori

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 10

Top Topics

Acute Lymphoblastic Leukemia

Prostate Cancer

Lower Urinary Tract Symptoms

Top Venues

Current oncology (Toronto, Ont.)

This page only lists publications with an associated author ORCID identifier.

Publications

Takahiro Yamaguchi, Masayuki Matsuo, Takayuki Mori, Yoshifumi Noda, Chiyoko Makita, Fuminori Hyodo, Koji Iinuma, Masahiro Nakano, Takuya Koie, Hidekazu Tanaka
Seed Density as a New Predictive Index of Seed Migration in Brachytherapy for Prostate Cancer Using Iodine-125 Loose Seed. Current oncology (Toronto, Ont.) 30 (4) (2023)
Shinichi Takeuchi, Koji Iinuma, Keita Nakane, Masahiro Nakano, Makoto Kawase, Kota Kawase, Manabu Takai, Daiki Kato, Takayuki Mori, Hirota Takano, Tomoyasu Kumano, Masayuki Matsuo, Takuya Koie
Direct Comparison of Two Different Definitions with Biochemical Recurrence after Low-Dose-Rate Brachytherapy for Prostate Cancer. Current oncology (Toronto, Ont.) 30 (3) (2023)
Masaya Ito, Chiyoko Makita, Takayuki Mori, Hirota Takano, Tomoyasu Kumano, Masayuki Matsuo, Koji Iinuma, Makoto Kawase, Keita Nakane, Masahiro Nakano, Takuya Koie
Associations of Clinical and Dosimetric Parameters with Urinary Toxicities after Prostate Brachytherapy: A Long-Term Single-Institution Experience. Current oncology (Toronto, Ont.) 30 (6) (2023)
Masaya Ito, Chiyoko Makita, Takayuki Mori, Hirota Takano, Tomoyasu Kumano, Masayuki Matsuo, Koji Iinuma, Makoto Kawase, Keita Nakane, Masahiro Nakano, Takuya Koie
Associations of Clinical and Dosimetric Parameters with Urinary Toxicities after Prostate Brachytherapy: A Long-Term Single-Institution Experience. Current oncology (Toronto, Ont.) 30 (6) (2023)
Masaya Ito, Chiyoko Makita, Takayuki Mori, Hirota Takano, Tomoyasu Kumano, Masayuki Matsuo, Koji Iinuma, Makoto Kawase, Keita Nakane, Masahiro Nakano, Takuya Koie
Associations of Clinical and Dosimetric Parameters with Urinary Toxicities after Prostate Brachytherapy: A Long-Term Single-Institution Experience. Current oncology (Toronto, Ont.) 30 (6) (2023)
Shinichi Takeuchi, Koji Iinuma, Keita Nakane, Masahiro Nakano, Makoto Kawase, Kota Kawase, Manabu Takai, Daiki Kato, Takayuki Mori, Hirota Takano, Tomoyasu Kumano, Masayuki Matsuo, Takuya Koie
Direct Comparison of Two Different Definitions with Biochemical Recurrence after Low-Dose-Rate Brachytherapy for Prostate Cancer. Current oncology (Toronto, Ont.) 30 (3) (2023)
Masaya Ito, Chiyoko Makita, Takayuki Mori, Hirota Takano, Tomoyasu Kumano, Masayuki Matsuo, Koji Iinuma, Makoto Kawase, Keita Nakane, Masahiro Nakano, Takuya Koie
Associations of Clinical and Dosimetric Parameters with Urinary Toxicities after Prostate Brachytherapy: A Long-Term Single-Institution Experience. Current oncology (Toronto, Ont.) 30 (6) (2023)
Shinichi Takeuchi, Koji Iinuma, Keita Nakane, Masahiro Nakano, Makoto Kawase, Kota Kawase, Manabu Takai, Daiki Kato, Takayuki Mori, Hirota Takano, Tomoyasu Kumano, Masayuki Matsuo, Takuya Koie
Direct Comparison of Two Different Definitions with Biochemical Recurrence after Low-Dose-Rate Brachytherapy for Prostate Cancer. Current oncology (Toronto, Ont.) 30 (3) (2023)
Takahiro Yamaguchi, Masayuki Matsuo, Takayuki Mori, Yoshifumi Noda, Chiyoko Makita, Fuminori Hyodo, Koji Iinuma, Masahiro Nakano, Takuya Koie, Hidekazu Tanaka
Seed Density as a New Predictive Index of Seed Migration in Brachytherapy for Prostate Cancer Using Iodine-125 Loose Seed. Current oncology (Toronto, Ont.) 30 (4) (2023)
Takahiro Yamaguchi, Masayuki Matsuo, Takayuki Mori, Yoshifumi Noda, Chiyoko Makita, Fuminori Hyodo, Koji Iinuma, Masahiro Nakano, Takuya Koie, Hidekazu Tanaka
Seed Density as a New Predictive Index of Seed Migration in Brachytherapy for Prostate Cancer Using Iodine-125 Loose Seed. Current oncology (Toronto, Ont.) 30 (4) (2023)